Search Results

Shionogi & Co., Ltd. announced the company is responding to the urgent global need for additional antimicrobial research and development by establishing its first discovery laboratory in the U.S., in San Diego, California.

SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.

SAB Biotherapeutics, Inc. today announced that the Navy Medical Research Command (NMRC) is moving forward with a safety and tolerability study to evaluate SAB-176.

Viracta Therapeutics, Inc. today announced that topline results from Stage 1 of the NAVAL-1 trial of Nana-val.

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, unveiled a new clinical research laboratory building at its good manufacturing practices lab in Middleton, Wisconsin.

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced the expansion of its central laboratory operations in Kentucky dedicated to accelerating pharmaceutical and biotech customers’ delivery of safe, effective medicines to patients.

Charles River Laboratories International, Inc. announced a multidisciplinary program, funded through a $1.3 million grant from the Foundation for Chemistry Research & Initiatives, in coordination with the American Chemistry Council’s Long-Range Research Initiative, to develop a New Approach Methodology inhalation toxicology test to reduce reliance on traditional animal research methods.

Dr. Reddy’s Laboratories Ltd. today announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).